Stay Ahead of Change with NAVLIN Daily’s Global Policy Watch

Pharmaceutical pricing policy has become increasingly global over the past few years, with changes happening at breakneck pace. The rise of Most-Favored Nation (MFN) in 2025 rapidly accelerated this trend, making it more essential than ever for market access professionals to have a broad view of policy developments.

However, the volume, speed, and complexity of these changes make it challenging to track and interpret the updates that matter most. That’s why we developed NAVLIN Daily’s Global Policy Watch.

Delivered weekly, this new service distills the most consequential policy and reimbursement developments across the U.S., Asia & South Pacific, Europe, Latin America, and other key regions—and translates them into actionable insights for pharmaceutical decision-makers.

Market Access and Pharmaceutical Pricing Strategies Must Become More Global

Across global markets, pharmaceutical pricing and access frameworks are undergoing some of the most significant reforms in years. In the U.S., the Inflation Reduction Act (IRA) continues to reshape pricing dynamics, CMS authority, and manufacturer contracting strategies. Meanwhile, ongoing efforts to implement Most-Favored Nation (MFN) pricing reflect the persistence of international reference pricing as a political and policy lever for the U.S. administration.

In Europe, Joint Clinical Assessment (JCA) under the EU HTA Regulation is transforming how evidence is evaluated at the EU level. The shift toward centralized assessment has major implications for timing, trial design, and the predictability of reimbursement outcomes. Member states are also intensifying cost control measures and experimenting with new modalities of transparency and budget impact management.

Beyond the U.S. and EU, governments worldwide are tightening policy around pricing, outcomes-based schemes, real-world evidence integration, tendering, and supply chain obligations. Many markets are pursuing various confidentiality measures in an attempt to shield net prices from the effects of MFN.

In short: change is everywhere, it’s accelerating, and it’s increasingly interconnected. What happens in one market influences expectations in others, amplifying the need for timely insights.

How NAVLIN Daily’s Global Policy Watch Can Help

Global Policy Watch was designed to fill the space between reports that are too dense to quickly consume and news updates that often fail to provide key insights on the impact of new policy developments.

Each weekly issue provides:

• The top pharma policy developments from the previous week, organized by region, and tailored to include the topics that matter most to pharmaceutical pricing and market access professionals

• A “Why it Matters” section that details the most important takeaways for each given policy

• Links to NAVLIN Daily’s news coverage of each development

• An “On the Horizon” scan to help you stay on top of key expected upcoming events, including policy updates and implementation milestones on reforms

Whether you’re developing market access strategies, preparing payer engagement, or supporting launch readiness, this newsletter helps you anticipate policy shifts before they hit your portfolio.

Sign Up Today

Don’t miss what’s coming next! To receive exclusive analysis and updates on the most important policy shifts taking place each week, subscribe to NAVLIN Daily’s Global Policy Watch by visiting our webpage or by contacting us.